Johns Hopkins Medicine: Study Affirms Benefit of Very Early Antiretroviral Therapy Within Hours of Birth for Newborns With HIV
December 06, 2023
December 06, 2023
BALTIMORE, Maryland, Dec. 6 (TNSres) -- Johns Hopkins Medicine issued the following news release:
A study of more than 50 babies through age 2 in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days -- rather than within weeks or months -- of life can safely suppress amounts of HIV in the blood to undetectable levels. Findings of the study, which was co-led by Johns Hopki . . .
A study of more than 50 babies through age 2 in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days -- rather than within weeks or months -- of life can safely suppress amounts of HIV in the blood to undetectable levels. Findings of the study, which was co-led by Johns Hopki . . .